Suppr超能文献

《丹佛发育筛查测验新加坡版:丹佛发育筛查测验第二版的新加坡版本》的现场测试

The field testing of Denver Developmental Screening Test Singapore: a Singapore version of Denver II Developmental Screening Test.

作者信息

Lim H C, Ho L Y, Goh L H, Ling S L, Heng R, Po G L

机构信息

Family Health Service, Singapore.

出版信息

Ann Acad Med Singap. 1996 Mar;25(2):200-9.

PMID:8799006
Abstract

The Denver Developmental Screening Test, Singapore (DDST, Singapore), a Singapore version of the Denver II Developmental Screening Test, was field-tested, using trained staff nurses as testers, on 2459 children (known cases excluded), in 5 key ages of 3 months, 9 months, 17 months, 37 months and 60 months. Only 2.6% (65) of the parents suspected developmental problems in their children before screening. Taking children with "questionable" (7.2%), "abnormal" (3.7%) and "untestable" (1.7%) scores as the screened-out cases, the DDST, Singapore had a screened-out rate of 12.6%. A total of 171 screened-out cases and 168 "normal" children were also evaluated by the Development Assessment Clinic (DAC) of the Singapore General Hospital and the results were compared in these 2 groups of children. Among the screened-out cases, 16.6% were confirmed or suspected to have neuro-developmental disorders (NDDs) by the DAC. The computed NDD rate in the study sample was 5.3%. Based on a single DDST, Singapore test result, there was a high false positive rate of 83.5% and lower false negative rate of 3.7% compared to the DAC assessment. However, the high false positive rate would be significantly reduced by doing a repeat screening test on the "questionable" cases and having the screened-out cases assessed by trained primary health care doctors. In conclusion, no major revision is needed in the scoring criteria suggested in the current version of DDST, Singapore. It is a useful tool in identifying children who will otherwise be missed without formal screening.

摘要

新加坡丹佛发育筛查测试(DDST,新加坡版)是丹佛二世发育筛查测试的新加坡版本,该测试以经过培训的护士为测试人员,对2459名儿童(不包括已知病例)进行了现场测试,这些儿童的年龄分别为3个月、9个月、17个月、37个月和60个月这5个关键年龄段。在筛查前,只有2.6%(65名)的家长怀疑自己孩子存在发育问题。将得分“可疑”(7.2%)、“异常”(3.7%)和“无法测试”(1.7%)的儿童视为筛查出的病例,新加坡版DDST的筛查率为12.6%。新加坡总医院发育评估诊所(DAC)还对总共171名筛查出的病例和168名“正常”儿童进行了评估,并在这两组儿童中比较了结果。在筛查出的病例中,DAC确认或怀疑16.6%患有神经发育障碍(NDD)。研究样本中的计算得出的NDD率为5.3%。与DAC评估相比,基于新加坡版DDST的单次测试结果,假阳性率高达83.5%,假阴性率较低,为3.7%。然而,通过对“可疑”病例进行重复筛查测试,并让经过培训的初级保健医生对筛查出的病例进行评估,高假阳性率将显著降低。总之,新加坡版DDST当前版本建议的评分标准无需重大修订。它是识别那些否则将在没有正式筛查的情况下被遗漏的儿童的有用工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验